AAN 2020 Data Release: Ofatumumab for Relapsing MS

Unknown block type "hrtag", specify a component for it in the `components.types` prop
Related Videos
Related Content

Sanofi Discontinues Phase 3 Study of Tolebrutinib in Myasthenia Gravis

February 7th 2023

Episode 76: ECTRIMS 2022 and the Latest in MS Advances

November 4th 2022

National Women Physicians Day: 10 Moments That Matter in Medicine

February 3rd 2023

Episode 75: Focusing on the Future of Neurology

October 21st 2022

Neuro News Roundup: Hot Topics and Key Insights From Women in Medicine

February 3rd 2023

Restless Legs Syndrome Severity in MS Decreased Through Exergaming

February 2nd 2023

Sanofi Discontinues Phase 3 Study of Tolebrutinib in Myasthenia Gravis

February 7th 2023

Episode 76: ECTRIMS 2022 and the Latest in MS Advances

November 4th 2022

National Women Physicians Day: 10 Moments That Matter in Medicine

February 3rd 2023

Episode 75: Focusing on the Future of Neurology

October 21st 2022

Neuro News Roundup: Hot Topics and Key Insights From Women in Medicine

February 3rd 2023

Restless Legs Syndrome Severity in MS Decreased Through Exergaming

February 2nd 2023

Sanofi Discontinues Phase 3 Study of Tolebrutinib in Myasthenia Gravis

February 7th 2023

Episode 76: ECTRIMS 2022 and the Latest in MS Advances

November 4th 2022

National Women Physicians Day: 10 Moments That Matter in Medicine

February 3rd 2023

Episode 75: Focusing on the Future of Neurology

October 21st 2022

Neuro News Roundup: Hot Topics and Key Insights From Women in Medicine

February 3rd 2023

Restless Legs Syndrome Severity in MS Decreased Through Exergaming

February 2nd 2023
About Us
Advisory Board
Editorial
Contact Us
Advertise
Contact MJH LS
Do Not Sell My Information
Terms and Conditions
Privacy
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.